MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
72.77
+1.14
+1.59%
After Hours: 72.77 0 0.00% 19:30 11/06 EST
OPEN
73.60
PREV CLOSE
71.63
HIGH
74.86
LOW
72.17
VOLUME
1.41M
TURNOVER
--
52 WEEK HIGH
126.38
52 WEEK LOW
28.66
MARKET CAP
7.96B
P/E (TTM)
57.21
1D
5D
1M
3M
1Y
5Y
1D
Lifyorli Sales Surge Could Reshape Corcept Therapeutics Stock Story
Simply Wall St · 2d ago
Corcept Therapeutics (CORT) Stock Trades At A Premium On Strong Q3 Earnings
Simply Wall St · 3d ago
Corcept Therapeutics (CORT) Gets a Buy from Canaccord Genuity
TipRanks · 3d ago
Top 3 Health Care Stocks You'll Regret Missing In Q4
Benzinga · 3d ago
AI-Driven Cyber and Data Security Risks Threaten Corcept Therapeutics’ Operations and Financial Performance
TipRanks · 3d ago
Piper Sandler Reiterates Overweight on Corcept Therapeutics, Raises Price Target to $173
Benzinga · 4d ago
Corcept Therapeutics (CORT) Q3 2026 Earnings Call Transcript
The Motley Fool · 4d ago
Corcept Therapeutics price target raised to $173 from $165 at Piper Sandler
TipRanks · 4d ago
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. It is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. It operates through the discovery, development and commercialization of the pharmaceutical products segment. It sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. It sells and distributes Lifyorli in the United States. It is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.